Yihong Deng

676 total citations · 1 hit paper
24 papers, 410 citations indexed

About

Yihong Deng is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yihong Deng has authored 24 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yihong Deng's work include Diabetes Management and Research (10 papers), Diabetes Treatment and Management (9 papers) and Thyroid Disorders and Treatments (4 papers). Yihong Deng is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes Treatment and Management (9 papers) and Thyroid Disorders and Treatments (4 papers). Yihong Deng collaborates with scholars based in United States, China and Hong Kong. Yihong Deng's co-authors include Joseph S. Ross, Nilay D. Shah, Xiaoxi Yao, Rozalina G. McCoy, Peter A. Noseworthy, Juan P. Brito, Víctor M. Montori, Kasia J. Lipska, Holly K. Van Houten and Rachel Giblon and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and BMJ.

In The Last Decade

Yihong Deng

24 papers receiving 408 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial

2022 135 citations Peter A. Noseworthy, Zachi I. Attia et al. The Lancet profile →

Peers

Yihong Deng

EDM

CCM

PRM

EPIDE

SURGE

John W. Ostrominski United States

Stefan D. Anker Germany

Nicoletta Musacchio Italy

Kaveh Hosseini Iran

Donna Parizadeh Iran

John K. Cuddeback United States

Renata Główczyńska Poland

Billy Wu New Zealand

Emma Behnken United States

Lawrence M. Phillips United States

John W. Ostrominski United States

Yihong Deng

185 ×1.1

EDM

230 ×1.5

CCM

24 ×0.5

PRM

92 ×2.1

EPIDE

54 ×1.3

SURGE

Citations per year, relative to Yihong Deng Yihong Deng (= 1×) peers John W. Ostrominski

Countries citing papers authored by Yihong Deng

Since Specialization

Citations

This map shows the geographic impact of Yihong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yihong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yihong Deng more than expected).

Fields of papers citing papers by Yihong Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yihong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yihong Deng. The network helps show where Yihong Deng may publish in the future.

Co-authorship network of co-authors of Yihong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Yihong Deng. A scholar is included among the top collaborators of Yihong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yihong Deng. Yihong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barkmeier, Andrew J., Yihong Deng, Jeph Herrin, et al.. (2025). Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice. Ophthalmology Retina. 10(2). 142–151. 1 indexed citations

Deng, Yihong, Eric C. Polley, Jeph Herrin, et al.. (2025). Heterogeneity of Cardiovascular Effects of Second‐Line Glucose‐Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk. Journal of the American Heart Association. 14(15). e040217–e040217. 1 indexed citations

Deng, Yihong, Jeph Herrin, Eric C. Polley, et al.. (2025). Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial. Diabetes Research and Clinical Practice. 229. 112910–112910. 1 indexed citations

Li, Ruoyu, Wenfeng Li, Xin Chen, et al.. (2025). Ameliorating macrophage pyroptosis via ANXA1/NLRP3/Caspase-1/GSDMD pathway: Ac2-26/OGP-loaded intelligent hydrogel enhances bone healing in diabetic periodontitis. Biofabrication. 17(2). 25001–25001. 4 indexed citations

Neumiller, Joshua J., Jeph Herrin, Eric C. Polley, et al.. (2024). Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk. Clinical Journal of the American Society of Nephrology. 20(2). 206–217. 2 indexed citations

Goldsweig, Andrew M., Yihong Deng, Xiaoxi Yao, et al.. (2024). Approval, Evidence, and “Off-Label” Device Utilization: The Patent Foramen Ovale Closure Story. Circulation Cardiovascular Quality and Outcomes. 17(1). e010200–e010200. 7 indexed citations

McCoy, Rozalina G., Jeph Herrin, Yihong Deng, et al.. (2024). Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk. Nature Cardiovascular Research. 3(4). 431–440. 8 indexed citations

McCoy, Rozalina G., Yihong Deng, Jeph Herrin, et al.. (2024). Derivation of an Annualized Claims-Based Major Adverse Cardiovascular Event Estimator in Type 2 Diabetes. JACC Advances. 3(4). 100852–100852. 9 indexed citations

Barkmeier, Andrew J., Jeph Herrin, Yihong Deng, et al.. (2024). Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy. Ophthalmology Retina. 8(10). 943–952. 12 indexed citations

10.

Riaz, Irbaz Bin, Harry E Fuentes, Yihong Deng, et al.. (2023). Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis. JAMA Network Open. 6(7). e2325283–e2325283. 21 indexed citations

11.

Deng, Yihong, Eric C. Polley, Joshua D. Wallach, et al.. (2023). Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial. SHILAP Revista de lepidopterología. 2(1). e000419–e000419. 4 indexed citations

12.

Noseworthy, Peter A., Zachi I. Attia, Emma Behnken, et al.. (2022). Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial. The Lancet. 400(10359). 1206–1212. 135 indexed citations breakdown →

13.

Brito, Juan P., Yihong Deng, Joseph S. Ross, et al.. (2022). Association Between Generic-to-Generic Levothyroxine Switching and Thyrotropin Levels Among US Adults. JAMA Internal Medicine. 182(4). 418–418. 10 indexed citations

14.

Haddad, Tufia C., Jordan Coffey, Yihong Deng, et al.. (2022). Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and Mortality. Mayo Clinic Proceedings. 97(12). 2215–2225. 14 indexed citations

15.

Brito, Juan P., Yihong Deng, Joseph S. Ross, et al.. (2022). Rates of, and factors associated with, switching among generic levothyroxine preparations in commercially insured American adults. Endocrine. 76(2). 349–358. 4 indexed citations

16.

Tan, Nicholas Y., Yihong Deng, Xiaoxi Yao, et al.. (2021). Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker. SHILAP Revista de lepidopterología. 5(2). 286–297. 6 indexed citations

17.

Brito, Juan P., Joseph S. Ross, Yihong Deng, et al.. (2021). Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use. Endocrine. 74(3). 592–602. 1 indexed citations

18.

Brito, Juan P., Joseph S. Ross, Spyridoula Maraka, et al.. (2021). Levothyroxine Use in the United States, 2008-2018. JAMA Internal Medicine. 181(10). 1402–1402. 51 indexed citations

19.

Wu, Xinyin, et al.. (2020). Methodological Quality of Systematic Reviews and Meta-Analysis on Asthma Treatments. A Cross-Sectional Study. Annals of the American Thoracic Society. 17(8). 949–957. 7 indexed citations

20.

Deng, Yihong, et al.. (2020). Proprotein convertase subtilisin/kexin type 9 inhibitor utilization and low-density lipoprotein-cholesterol control in familial hypercholesterolemia. Journal of clinical lipidology. 15(2). 339–346. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact